• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巨噬细胞衍生的肿瘤坏死因子以及肿瘤衍生的白血病抑制因子和白细胞介素-6:癌症恶病质可能的细胞机制。

Macrophage-derived tumor necrosis factor and tumor-derived of leukemia inhibitory factor and interleukin-6: possible cellular mechanisms of cancer cachexia.

作者信息

Billingsley K G, Fraker D L, Strassmann G, Loeser C, Fliot H M, Alexander H R

机构信息

National Cancer Institute/National Institutes of Health, Bethesda, MD 20892, USA.

出版信息

Ann Surg Oncol. 1996 Jan;3(1):29-35. doi: 10.1007/BF02409048.

DOI:10.1007/BF02409048
PMID:8770299
Abstract

BACKGROUND

The cellular basis for augmented cytokine production in the tumor-bearing host is not known. Recently leukemia inhibitory factor (LIF) and interleukin (IL)-6, produced by a variety of tumors, have been implicated as mediators of cachexia.

METHODS

Five murine tumor cell lines were tested for the production of these cytokines. 4JK tumor was further tested to determine if IL-1, tumor necrosis factor (TNF), or cocultivation with RAW 264 cells augmented IL-6 or LIF production.

RESULTS

4JK from in vivo tumors produced significantly more IL-6 than did 4JK from culture, indicating that tumor production of IL-6 and LIF is potentially augmented by infiltrating macrophages. When 4JK was cocultured with RAW 264 cells, TNF, or IL-1 in vitro, a three- to 15-fold increase in tumor production of LIF and IL-6 was noted (p2 < or = 0.03). Conversely, in coculture experiments performed with a neutralizing TNF antibody, a 50% reduction in tumor production of LIF ad IL-6 was noted (p2 < 0.04). Resting RAW cells produced only minimal quantities of TNF; however, when RAW cells were exposed to tumor-conditioned supernatant from 4JK, their TNF production was markedly increased.

CONCLUSIONS

In the tumor microenvironment, host macrophages may be activated and produce inflammatory cytokines such as TNF. Local TNF then appears to act on tumor cells to stimulate production of IL-6 and LIF. Enhanced tumor production of cytokine mediators may contribute to deleterious effects of neoplastic growth on the host.

摘要

背景

荷瘤宿主中细胞因子产生增加的细胞基础尚不清楚。最近,多种肿瘤产生的白血病抑制因子(LIF)和白细胞介素(IL)-6被认为是恶病质的介质。

方法

检测了五种小鼠肿瘤细胞系中这些细胞因子的产生情况。对4JK肿瘤进一步检测,以确定IL-1、肿瘤坏死因子(TNF)或与RAW 264细胞共培养是否会增加IL-6或LIF的产生。

结果

体内肿瘤来源的4JK产生的IL-6明显多于培养的4JK,这表明浸润的巨噬细胞可能会增强肿瘤IL-6和LIF的产生。当4JK在体外与RAW 264细胞、TNF或IL-1共培养时,LIF和IL-6的肿瘤产生量增加了3至15倍(P2≤0.03)。相反,在用中和性TNF抗体进行的共培养实验中,LIF和IL-6的肿瘤产生量减少了50%(P2<0.04)。静止的RAW细胞仅产生少量的TNF;然而,当RAW细胞暴露于4JK的肿瘤条件培养基上清液时,它们的TNF产生量明显增加。

结论

在肿瘤微环境中,宿主巨噬细胞可能被激活并产生炎症细胞因子,如TNF。局部TNF似乎作用于肿瘤细胞以刺激IL-6和LIF的产生。肿瘤细胞因子介质产生的增强可能导致肿瘤生长对宿主产生有害影响。

相似文献

1
Macrophage-derived tumor necrosis factor and tumor-derived of leukemia inhibitory factor and interleukin-6: possible cellular mechanisms of cancer cachexia.巨噬细胞衍生的肿瘤坏死因子以及肿瘤衍生的白血病抑制因子和白细胞介素-6:癌症恶病质可能的细胞机制。
Ann Surg Oncol. 1996 Jan;3(1):29-35. doi: 10.1007/BF02409048.
2
Expression of interleukin (IL)-11 receptor by the human endometrium in vivo and effects of IL-11, IL-6 and LIF on the production of MMP and cytokines by human endometrial cells in vitro.白细胞介素(IL)-11受体在人子宫内膜中的体内表达以及IL-11、IL-6和白血病抑制因子(LIF)对人子宫内膜细胞体外基质金属蛋白酶(MMP)和细胞因子产生的影响。
Mol Hum Reprod. 2002 Sep;8(9):841-8. doi: 10.1093/molehr/8.9.841.
3
Selective up-regulation of tumor necrosis factor receptor I in tumor-bearing rats with cancer-related cachexia.肿瘤相关恶病质荷瘤大鼠中肿瘤坏死因子受体I的选择性上调
Int J Oncol. 2003 Aug;23(2):429-36.
4
Toxohormones responsible for cancer cachexia syndrome in nude mice bearing human cancer cell lines.负责荷人类癌细胞系裸鼠癌症恶病质综合征的毒素激素。
Cancer Chemother Pharmacol. 1996;38 Suppl:S48-52. doi: 10.1007/s002800051038.
5
HILDA/LIF, G.CSF, IL-1 beta, IL-6, and TNF alpha production during acute rejection of human kidney allografts.人肾移植急性排斥反应期间HILDA/LIF、粒细胞集落刺激因子、白细胞介素-1β、白细胞介素-6和肿瘤坏死因子α的产生
Transplantation. 1993 Sep;56(3):597-602. doi: 10.1097/00007890-199309000-00019.
6
Role of cytokines in cancer cachexia in a murine model of intracerebral injection of human tumours.细胞因子在人脑内注射人类肿瘤小鼠模型的癌症恶病质中的作用
Cytokine. 2001 Jul 7;15(1):27-38. doi: 10.1006/cyto.2001.0899.
7
Differential effects of IL-8, LIF (pro-inflammatory) and IL-11 (anti-inflammatory) on TNF-alpha-induced PGE(2)release and on signalling pathways in human OA synovial fibroblasts.白细胞介素-8、白血病抑制因子(促炎)和白细胞介素-11(抗炎)对肿瘤坏死因子-α诱导的人骨关节炎滑膜成纤维细胞中前列腺素E2释放及信号通路的不同影响。
Cytokine. 1999 Dec;11(12):1020-30. doi: 10.1006/cyto.1999.0505.
8
Experimental cancer cachexia: the role of host-derived cytokines interleukin (IL)-6, IL-12, interferon-gamma, and tumor necrosis factor alpha evaluated in gene knockout, tumor-bearing mice on C57 Bl background and eicosanoid-dependent cachexia.实验性癌症恶病质:在基因敲除的、携带肿瘤的C57 Bl背景小鼠以及类二十烷酸依赖性恶病质中评估宿主来源的细胞因子白细胞介素(IL)-6、IL-12、γ干扰素和肿瘤坏死因子α的作用。
Cancer Res. 2000 Oct 1;60(19):5488-93.
9
Tumor necrosis factor alpha stimulates production of leukemia inhibitory factor in human dermal fibroblast cultures.肿瘤坏死因子α刺激人皮肤成纤维细胞培养物中白血病抑制因子的产生。
Clin Immunol Immunopathol. 1994 Mar;70(3):260-5. doi: 10.1006/clin.1994.1038.
10
Production of leukemia inhibitory factor by human articular chondrocytes and cartilage in response to interleukin-1 and tumor necrosis factor alpha.人关节软骨细胞和软骨对白细胞介素-1和肿瘤坏死因子α的反应中白血病抑制因子的产生。
Arthritis Rheum. 1993 Jun;36(6):790-4. doi: 10.1002/art.1780360608.

引用本文的文献

1
The Molecular Basis and Therapeutic Potential of Leukemia Inhibitory Factor in Cancer Cachexia.白血病抑制因子在癌症恶病质中的分子基础及治疗潜力
Cancers (Basel). 2022 Jun 15;14(12):2955. doi: 10.3390/cancers14122955.
2
Drosophila as a Model for Tumor-Induced Organ Wasting.果蝇作为肿瘤诱导器官消耗的模型。
Adv Exp Med Biol. 2019;1167:191-205. doi: 10.1007/978-3-030-23629-8_11.
3
Macrophage Depletion in Elderly Mice Improves Response to Tumor Immunotherapy, Increases Anti-tumor T Cell Activity and Reduces Treatment-Induced Cachexia.

本文引用的文献

1
Mechanisms of experimental cancer cachexia. Local involvement of IL-1 in colon-26 tumor.实验性癌症恶病质的机制。白细胞介素-1在结肠26肿瘤中的局部作用。
J Immunol. 1993 Mar 15;150(6):2341-5.
2
Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group.癌症患者化疗前体重减轻的预后影响。东部肿瘤协作组。
Am J Med. 1980 Oct;69(4):491-7. doi: 10.1016/s0149-2918(05)80001-3.
3
Protein-calorie undernutrition in hospitalized cancer patients.住院癌症患者的蛋白质 - 热量营养不良
老年小鼠体内巨噬细胞的清除可改善对肿瘤免疫疗法的反应、增强抗肿瘤T细胞活性并减轻治疗引起的恶病质。
Front Genet. 2018 Nov 6;9:526. doi: 10.3389/fgene.2018.00526. eCollection 2018.
4
Systemic Inflammation in Cachexia - Is Tumor Cytokine Expression Profile the Culprit?恶病质中的全身炎症——肿瘤细胞因子表达谱是罪魁祸首吗?
Front Immunol. 2015 Dec 24;6:629. doi: 10.3389/fimmu.2015.00629. eCollection 2015.
5
Hochuekkito (TJ-41), a Kampo Formula, Ameliorates Cachexia Induced by Colon 26 Adenocarcinoma in Mice.和汉消积汤(TJ-41)改善结肠癌 26 荷瘤小鼠恶病质
Evid Based Complement Alternat Med. 2012;2012:976926. doi: 10.1155/2012/976926. Epub 2012 Dec 24.
6
Comparative analysis of macrophage associated vectors for use in genetic vaccine.用于基因疫苗的巨噬细胞相关载体的比较分析
Genet Vaccines Ther. 2011 Jun 18;9(1):10. doi: 10.1186/1479-0556-9-10.
7
Myeloid-derived suppressor cells in cancer cachexia syndrome: a new explanation for an old problem.癌症恶病质综合征中的髓源性抑制细胞:一个老问题的新解释。
JPEN J Parenter Enteral Nutr. 2008 Nov-Dec;32(6):651-5. doi: 10.1177/0148607108325075.
8
IL-6-like cytokines and cancer cachexia: consequences of chronic inflammation.白细胞介素-6样细胞因子与癌症恶病质:慢性炎症的后果
Immunol Res. 2001;23(1):41-58. doi: 10.1385/IR:23:1:41.
Am J Med. 1980 May;68(5):683-90. doi: 10.1016/0002-9343(80)90254-5.
4
Cachectin/tumor necrosis factor: a possible mediator of cancer anorexia in the rat.恶病质素/肿瘤坏死因子:大鼠癌症性厌食的一种可能介质。
Cancer Res. 1988 Aug 15;48(16):4567-72.
5
Evidence for tumour necrosis factor/cachectin production in cancer.癌症中肿瘤坏死因子/恶病质素产生的证据。
Lancet. 1987 Nov 28;2(8570):1229-32. doi: 10.1016/s0140-6736(87)91850-2.
6
Passive immunization against tumor necrosis factor partially abrogates interleukin 2 toxicity.针对肿瘤坏死因子的被动免疫部分消除了白细胞介素2的毒性。
J Exp Med. 1989 Sep 1;170(3):1015-20. doi: 10.1084/jem.170.3.1015.
7
Anticachectin/tumor necrosis factor-alpha antibodies attenuate development of cachexia in tumor models.抗恶病质素/肿瘤坏死因子-α抗体可减轻肿瘤模型中恶病质的发展。
FASEB J. 1989 Jun;3(8):1956-62. doi: 10.1096/fasebj.3.8.2721856.
8
Induction of interferon-beta 2/interleukin-6 (IL-6) by cytokine administration and detection of circulating interleukin-6 in the tumor-bearing state.通过给予细胞因子诱导干扰素-β2/白细胞介素-6(IL-6)并检测荷瘤状态下循环中的白细胞介素-6
Ann N Y Acad Sci. 1989;557:157-60; discussion 160-1. doi: 10.1111/j.1749-6632.1989.tb24008.x.
9
Cachectic effects of recombinant human tumor necrosis factor in rats.重组人肿瘤坏死因子对大鼠的恶病质作用
Cancer Res. 1990 Jul 1;50(13):4008-13.
10
Mechanisms of cancer cachexia.癌症恶病质的机制。
Hematol Oncol Clin North Am. 1991 Feb;5(1):103-23.